The answer is no; both atorvastatin (also called Lipitor) and simvastatin (also called Zocor) have been studied in different populations of MS patients with mixed results. Neither statin has definitely been shown to be effective in any MS population, to say nothing about one being more effective than the other. Until phase III studies demonstrate a benefit, it is far too early to recommend any statin therapy to treat MS alone. Those on statin therapy for other reasons (elevated cholesterol, cardiovascular risk) should feel confident in continuing their current statin therapy, if it is working and well tolerated.
PLEASE NOTE: The information/opinions on this site should be used as an information resource only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.